EGFR/CSC-IN-1

EGFR/CSC-IN-1 is a potent dual-targeting small molecule inhibitor of EGFR (IC50 = 10.52 nM) and cancer stem cells. It is a valuable research tool for investigating therapeutic strategies, particularly in triple-negative breast cancer models, in both in vitro and in vivo experimental settings.